Normabel (Diazepam)

Diazepam binds to a specific site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This increases the frequency of chloride channel opening when GABA binds, leading to greater chloride influx, neuronal hyperpolarisation, and consequently reduced excitability, producing anxiolytic, sedative, muscle‑relaxant and anticonvulsant effects.

The appropriate dose of Normabel is determined by the prescribing clinician based on the individual’s medical condition, age, liver function and concomitant therapies. Dosage regimens can vary widely, and patients should follow the specific instructions provided by their healthcare professional.

Normabel is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should be avoided during pregnancy unless the therapeutic benefit justifies the potential hazard. Diazepam is excreted in breast milk and may affect a nursing infant, so alternative treatments are generally preferred.

To order Normabel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Normabel (diazepam) has a longer half‑life and a broader spectrum of indications compared with shorter‑acting agents like lorazepam. Diazepam provides prolonged anxiolytic and muscle‑relaxant effects, which can be advantageous for certain chronic conditions, whereas lorazepam may be preferred when rapid clearance is desired to minimise accumulation.

Normabel should be stored at ambient temperature below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Normabel is administered orally, typically as a tablet that is swallowed whole with water. The exact route (e.g., with or without food) and frequency are determined by the prescribing clinician based on the therapeutic indication and patient response.

Serious risks include respiratory depression, severe hypotension, development of physical dependence, withdrawal seizures on abrupt discontinuation, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience difficulty breathing, extreme drowsiness, or any severe skin changes.

Normabel is contraindicated in individuals with known hypersensitivity to diazepam or other benzodiazepines, patients with acute narrow‑angle glaucoma, and those with severe respiratory insufficiency. Caution is also advised for patients with a history of substance misuse, severe hepatic impairment, or those taking other central nervous system depressants.